These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. FOXP3 expression and overall survival in breast cancer. Merlo A; Casalini P; Carcangiu ML; Malventano C; Triulzi T; Mènard S; Tagliabue E; Balsari A J Clin Oncol; 2009 Apr; 27(11):1746-52. PubMed ID: 19255331 [TBL] [Abstract][Full Text] [Related]
3. A new measure of prognostic separation in survival data. Royston P; Sauerbrei W Stat Med; 2004 Mar; 23(5):723-48. PubMed ID: 14981672 [TBL] [Abstract][Full Text] [Related]
4. Analysis of additive risk model with high-dimensional covariates using partial least squares. Zhao Y; Zhou Y; Zhao M Stat Med; 2009 Jan; 28(2):181-93. PubMed ID: 18800330 [TBL] [Abstract][Full Text] [Related]
5. Conditional survival of patients with diffuse large B-cell lymphoma. Moller MB; Pedersen NT; Christensen BE Cancer; 2006 May; 106(10):2165-70. PubMed ID: 16586498 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer. Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997 [TBL] [Abstract][Full Text] [Related]
7. Variance estimation of a survival function for interval-censored survival data. Sun J Stat Med; 2001 Apr; 20(8):1249-57. PubMed ID: 11304740 [TBL] [Abstract][Full Text] [Related]
8. Adapting prediction error estimates for biased complexity selection in high-dimensional bootstrap samples. Binder H; Schumacher M Stat Appl Genet Mol Biol; 2008; 7(1):Article12. PubMed ID: 18384265 [TBL] [Abstract][Full Text] [Related]
9. Survival analysis using auxiliary variables via non-parametric multiple imputation. Hsu CH; Taylor JM; Murray S; Commenges D Stat Med; 2006 Oct; 25(20):3503-17. PubMed ID: 16345047 [TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer. Jiang WG; Douglas-Jones AG; Mansel RE Prostaglandins Leukot Essent Fatty Acids; 2006 Feb; 74(2):125-34. PubMed ID: 16364620 [TBL] [Abstract][Full Text] [Related]
11. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients. Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621 [TBL] [Abstract][Full Text] [Related]
12. Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data. Gui J; Li H Bioinformatics; 2005 Jul; 21(13):3001-8. PubMed ID: 15814556 [TBL] [Abstract][Full Text] [Related]
13. Population-based molecular prognosis of breast cancer by transcriptional profiling. Ma Y; Qian Y; Wei L; Abraham J; Shi X; Castranova V; Harner EJ; Flynn DC; Guo L Clin Cancer Res; 2007 Apr; 13(7):2014-22. PubMed ID: 17404081 [TBL] [Abstract][Full Text] [Related]
14. A general, prediction error-based criterion for selecting model complexity for high-dimensional survival models. Porzelius C; Schumacher M; Binder H Stat Med; 2010 Mar; 29(7-8):830-8. PubMed ID: 20213716 [TBL] [Abstract][Full Text] [Related]
15. Logical analysis of survival data: prognostic survival models by detecting high-degree interactions in right-censored data. Kronek LP; Reddy A Bioinformatics; 2008 Aug; 24(16):i248-53. PubMed ID: 18689833 [TBL] [Abstract][Full Text] [Related]
16. Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer. Lin YH; Friederichs J; Black MA; Mages J; Rosenberg R; Guilford PJ; Phillips V; Thompson-Fawcett M; Kasabov N; Toro T; Merrie AE; van Rij A; Yoon HS; McCall JL; Siewert JR; Holzmann B; Reeve AE Clin Cancer Res; 2007 Jan; 13(2 Pt 1):498-507. PubMed ID: 17255271 [TBL] [Abstract][Full Text] [Related]
17. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival. Cheang MC; Treaba DO; Speers CH; Olivotto IA; Bajdik CD; Chia SK; Goldstein LC; Gelmon KA; Huntsman D; Gilks CB; Nielsen TO; Gown AM J Clin Oncol; 2006 Dec; 24(36):5637-44. PubMed ID: 17116944 [TBL] [Abstract][Full Text] [Related]
19. Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma. Banham AH; Connors JM; Brown PJ; Cordell JL; Ott G; Sreenivasan G; Farinha P; Horsman DE; Gascoyne RD Clin Cancer Res; 2005 Feb; 11(3):1065-72. PubMed ID: 15709173 [TBL] [Abstract][Full Text] [Related]
20. Efron-type measures of prediction error for survival analysis. Gerds TA; Schumacher M Biometrics; 2007 Dec; 63(4):1283-7. PubMed ID: 17651459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]